Related Experiment Video
Updated: May 28, 2025
Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
Published on: June 1, 2022
Can Coenzyme Q10 Supplementation Reduce Cardiovascular Disease Risk Factors? A Protocol for a GRADE-Assessed
Ali Jafari1,2
1Student Research Committee, Department of Community Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute Shahid Beheshti University of Medical Sciences Tehran Iran.
Insights
Coenzyme Q10 (CoQ10) supplementation may benefit cardiovascular health by improving risk factors like blood pressure and lipid profiles. This systematic review synthesizes evidence from randomized controlled trials to guide clinical treatment.
Area of Science:
- Nutritional Biochemistry
- Cardiovascular Medicine
- Evidence Synthesis
Background:
- Cardiovascular diseases (CVDs) are a major global health concern.
- Coenzyme Q10 (CoQ10), a natural antioxidant, is investigated for its cardiovascular benefits.
- CoQ10 is vital for cellular energy production and has therapeutic applications.
Purpose of the Study:
- To systematically analyze the scientific literature on CoQ10 supplementation's effects on CVD risk factors.
- To evaluate impacts on glycemic, lipid, and anthropometric profiles, blood pressure, inflammation, liver function, oxidative stress, and adipokines.
- To provide a basis for evidence-based clinical treatment strategies.
Main Methods:
- Systematic electronic search of major databases (PubMed, Scopus, Web of Science, CENTRAL, EMBASE) up to July 2024.
- Inclusion of randomized controlled trials (RCTs) in healthy and unhealthy participants.
- Data extraction and quality assessment using Cochrane risk of bias tool, with potential for meta-analysis.
Main Results:
- The review will synthesize findings on CoQ10's impact across multiple CVD risk indicators.
- Comprehensive analysis of effects on glycemic control, lipid profiles, and blood pressure.
- Evaluation of changes in inflammatory markers, oxidative stress, and adipokines.
Conclusions:
- This protocol details a rigorous systematic review and meta-analysis of CoQ10 supplementation for CVD risk factors.
- The study aims to deliver high-quality evidence synthesis from RCTs.
- Findings will inform clinical practice regarding CoQ10's role in managing cardiovascular health.
Background And Aims:
Cardiovascular diseases (CVDs), encompassing a variety of conditions affecting the heart and blood vessels, remain a significant global public health challenge. Among various therapeutic options, Coenzyme Q10 (CoQ10) has garnered attention due to its potential benefits for cardiovascular health. CoQ10 is a naturally occurring antioxidant that plays a crucial role in cellular energy production and has long been used therapeutically. This study aims to summarize and systematically analyze the scientific literature on glycemic profile, lipid profile, anthropometric measures, blood pressure, inflammatory factors, liver function tests, oxidative stress parameters and adipokines associated with CoQ10 supplementation to provide a basis for clinical treatment.
Methods:
A systematic electronic search will be conducted to identify articles published from inception to July 2024 across databases including PubMed, Scopus, Web of Science, CENTRAL, and EMBASE. The search will focus on randomized controlled trials (RCTs) involving both healthy and unhealthy participants. Two independent reviewers will evaluate articles, extract data, and assess study quality using the Cochrane risk of bias tool. Discrepancies will be resolved through consultation with a third reviewer. If a sufficient number of eligible studies are identified, a meta-analysis will be performed on the selected outcomes.
Results:
The results will provide a comprehensive synthesis of the effects of CoQ10 supplementation on cardiovascular disease risk factors, including glycemic profile, lipid profile, anthropometric measures, blood pressure, inflammatory factors, liver function tests, oxidative stress parameters, and adipokines.
Conclusion:
This protocol outlines a comprehensive approach to systematically review and perform a dose-response meta-analysis on the effects of CoQ10 supplementation on CVD risk factors. The study will employ rigorous methodologies, including independent evaluation and GRADE assessment, to ensure high-quality evidence synthesis from RCTs.
More Related Videos
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
01:27Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...